Question 1

How much does stem cell therapy for knees cost?

Accepted Answer

There is no responsible universal price before diagnosis, imaging, laterality, product identity, route, facility fees, and follow-up are known. Any quote should be itemized and should not imply that a lower price establishes quality, safety, or effectiveness.

Question 2

What is the success rate of stem cell therapy for knees?

Accepted Answer

There is no single credible success rate. Studies use different products, comparators, osteoarthritis grades, and pain or function endpoints. A useful discussion should name the exact study, the size of any change, the time point, adverse events, and whether the result applies to the proposed product.

Question 3

Can stem cell treatment replace knee surgery?

Accepted Answer

It should not be presented as a predictable replacement for surgery. The appropriate pathway depends on diagnosis, structural severity, symptoms, function, established non-surgical care, and an orthopedic opinion when surgery is being considered.

Question 4

Is stem cell therapy effective for knee osteoarthritis?

Accepted Answer

Research findings are product-specific and do not validate every MSC, exosome, or injection package. Evidence should be discussed by osteoarthritis grade, comparator, endpoint, follow-up, and product, without promising cartilage restoration or a predictable response.

Question 5

Which orthopedic conditions do you review?

Accepted Answer

Reviews may involve knee or hip osteoarthritis, shoulder and rotator cuff disease, sports injuries, back or facet-related pain, and tendon or ligament problems. The first task is to confirm the diagnosis and established care pathway, not assume one regenerative procedure fits them all.

Question 6

Do I need to bring my MRI or imaging?

Accepted Answer

Yes — recent MRI, X-ray or ultrasound greatly helps planning, and we cannot finalize a program without imaging review. Our coordinators will tell you exactly what to send before your consultation. Imaging older than 12 months may need to be repeated; we will let you know.

Question 7

How quickly can I return to sport after a regenerative procedure?

Accepted Answer

There is no generic return-to-sport timetable. Progression should be set by the diagnosis, tissue and procedure, baseline function, symptoms, objective strength or load criteria, and the treating rehabilitation team.

Question 8

Are the applications painful?

Accepted Answer

Pain and other procedural effects vary by target, route, guidance method, and individual factors. The proposed comfort measures, expected recovery, warning signs, and contact plan should be explained before consent.

Question 9

How long is an orthopedic review in Istanbul?

Accepted Answer

Duration depends on the records and imaging needed, whether a procedure is actually appropriate, observation requirements, and travel fitness. It should be confirmed after clinical review rather than advertised as one standard package.

Question 10

How much does an orthopedic stem cell program cost?

Accepted Answer

Cost depends on the joints or tendons involved, cell dose, whether exosome support is integrated, the number of sessions and your length of stay. After your free consultation and imaging review, you receive a clear, itemized proposal — we do not publish list prices because every plan is individually quoted.

Question 11

When will I notice improvement after the procedure?

Accepted Answer

No product can support a universal improvement timeline, and no change is possible. Baseline pain and function measures, a rehabilitation plan, and condition-appropriate reassessment points should be agreed before an investigational procedure.

Question 12

Can I have stem cell therapy on more than one joint?

Accepted Answer

Multi-joint treatment should not be assumed. Each symptomatic joint needs diagnosis and imaging context, and the overall procedure burden, product exposure, rehabilitation demands, and alternatives require individual review.

Question 13

Is rehab or physiotherapy needed after the procedure?

Accepted Answer

Rehabilitation is part of established care for many joint, tendon, and spine conditions. The treating clinician and physiotherapist should define loading, movement, and return-to-activity guidance for the exact diagnosis and procedure.

Question 14

Are there side effects from intra-articular stem cell injections?

Accepted Answer

Risks vary with the product, preparation, sterility controls, dose, guidance, joint, medicines, and patient factors. Written consent should cover known procedure risks, product uncertainties, alternatives, monitoring, and what happens if symptoms worsen.

Question 15

Can stem cell therapy help tennis elbow or golfer's elbow?

Accepted Answer

A diagnosis and an established loading or rehabilitation plan come first. Evidence for any injection is product-specific, and a cell or exosome proposal should not promise tendon regeneration or a predictable return to activity.

Question 16

Do you treat degenerative disc disease with stem cells?

Accepted Answer

Degenerative findings on imaging do not by themselves identify the pain source. Established spine assessment and care come first, and intradiscal or other cell-based approaches remain investigational and product-specific.

Question 17

Is stem cell therapy used for osteoporosis or bone healing?

Accepted Answer

Cell or exosome therapy is not an established substitute for osteoporosis treatment or standard fracture, delayed-union, or avascular-necrosis care. These diagnoses require their own specialist assessment and evidence pathway.

Question 18

Can stem cells help Achilles tendinopathy or plantar fasciitis?

Accepted Answer

A generic yes is not supported. Diagnosis, load management, and established rehabilitation come first. Any cell or exosome injection should be described as product-specific and investigational, with no promised tissue regeneration or recovery timetable.

Question 19

Where are orthopedic procedures performed in Istanbul?

Accepted Answer

The proposed facility, operator, imaging guidance, product handling, emergency arrangements, and follow-up should be disclosed before booking. Location and physician supervision do not by themselves establish effectiveness or remove risk.

Question 20

Will you collaborate with my orthopedic surgeon?

Accepted Answer

Yes, gladly. Sharing your imaging, surgical opinions and current rehab plan helps us design a safer, better-integrated regenerative strategy — particularly for patients considering surgery later or recovering from a recent procedure.

Joint, tendon and spine-focused regenerative planning.

Function-driven, individually planned care.

Built around diagnosis, imaging, and function.

Diagnostic fit

Established care

Outcome baseline

Product-specific evidence

Areas we plan around.

Intra-articular

Intramuscular

Intravenous

Regenerative care, in proper context.

Frequently Asked Questions

Begin a personalized treatment conversation with our medical team.